Meningiomas, the most common primary intracranial tumors, present unique challenges in treatment and management. Recent studies have focused on enhancing treatment precision through advanced imaging and radiotherapy techniques. For instance, Perlow et al. proposed consensus guidelines for radiation treatment planning using (68)Ga-DOTATATE PET/CT, emphasizing that PET-guided radiation can improve local control and minimize toxicity by allowing for precise dose escalation (ref: Perlow doi.org/10.1016/j.ijrobp.2024.12.003/). In a multicenter study, Kim et al. developed a prognostic model using machine learning to predict progression-free survival in patients with atypical meningiomas, highlighting the ongoing debate regarding the role of adjuvant radiotherapy (ref: Kim doi.org/10.1016/j.radonc.2024.110695/). Furthermore, Lesueur et al. initiated a randomized controlled trial comparing proton therapy to conventional radiotherapy for cavernous sinus meningiomas, which may offer insights into optimizing treatment modalities (ref: Lesueur doi.org/10.1186/s12885-024-13353-9/). The integration of preoperative embolization techniques, as demonstrated by Essibayi et al., has shown promise in facilitating surgical resection by reducing tumor vascularity (ref: Essibayi doi.org/10.3174/ajnr.A8624/). Additionally, Hafazalla et al. explored the improvement of cranial neuropathies following stereotactic radiotherapy, providing valuable data on treatment outcomes (ref: Hafazalla doi.org/10.1080/02688697.2024.2427720/). Lastly, innovative surgical techniques, such as the multilayered membrane repair for cerebrospinal fluid leaks during endonasal tumor resection, have been introduced by Shao et al., indicating a shift towards more refined surgical approaches (ref: Shao doi.org/10.62347/ZIFY3189/).